Annual Cash & Cash Equivalents
$190.00 K
-$167.00 K-46.78%
31 December 2023
Summary:
BioSig Technologies annual cash & cash equivalents is currently $190.00 thousand, with the most recent change of -$167.00 thousand (-46.78%) on 31 December 2023. During the last 3 years, it has fallen by -$11.47 million (-98.37%). BSGM annual cash & cash equivalents is now -99.33% below its all-time high of $28.27 million, reached on 31 December 2020.BSGM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$615.00 K
-$1.49 M-70.77%
30 September 2024
Summary:
BioSig Technologies quarterly cash and cash equivalents is currently $615.00 thousand, with the most recent change of -$1.49 million (-70.77%) on 30 September 2024. Over the past year, it has increased by +$425.00 thousand (+223.68%). BSGM quarterly cash and cash equivalents is now -98.33% below its all-time high of $36.93 million, reached on 30 June 2020.BSGM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BSGM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +223.7% |
| 3 y3 years | -98.4% | -94.7% |
| 5 y5 years | -98.4% | -94.9% |
BSGM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -98.4% | at low | -94.7% | +223.7% |
| 5 y | 5 years | -99.3% | at low | -98.3% | +223.7% |
| alltime | all time | -99.3% | at low | -98.3% | +1357.3% |
BioSig Technologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $615.00 K(-70.8%) |
| June 2024 | - | $2.10 M(+405.8%) |
| Mar 2024 | - | $416.00 K(+118.9%) |
| Dec 2023 | $190.00 K(-46.8%) | $190.00 K(-51.2%) |
| Sept 2023 | - | $389.00 K(-68.9%) |
| June 2023 | - | $1.25 M(-11.3%) |
| Mar 2023 | - | $1.41 M(+295.5%) |
| Dec 2022 | $357.00 K(-96.9%) | $357.00 K(-59.8%) |
| Sept 2022 | - | $887.00 K(-82.5%) |
| June 2022 | - | $5.08 M(-41.4%) |
| Mar 2022 | - | $8.66 M(-25.7%) |
| Dec 2021 | $11.66 M(-58.8%) | $11.66 M(-33.5%) |
| Sept 2021 | - | $17.54 M(+13.1%) |
| June 2021 | - | $15.50 M(-31.0%) |
| Mar 2021 | - | $22.48 M(-20.5%) |
| Dec 2020 | $28.27 M(+133.4%) | $28.27 M(-13.7%) |
| Sept 2020 | - | $32.75 M(-11.3%) |
| June 2020 | - | $36.93 M(+138.2%) |
| Mar 2020 | - | $15.50 M(+28.0%) |
| Dec 2019 | $12.11 M | $12.11 M(-1.6%) |
| Sept 2019 | - | $12.31 M(+19.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $10.33 M(-5.5%) |
| Mar 2019 | - | $10.93 M(+145.7%) |
| Dec 2018 | $4.45 M(+187.6%) | $4.45 M(-38.9%) |
| Sept 2018 | - | $7.28 M(+98.2%) |
| June 2018 | - | $3.67 M(+254.9%) |
| Mar 2018 | - | $1.04 M(-33.1%) |
| Dec 2017 | $1.55 M(+46.6%) | $1.55 M(+560.5%) |
| Sept 2017 | - | $234.30 K(-73.4%) |
| June 2017 | - | $880.70 K(-29.2%) |
| Mar 2017 | - | $1.24 M(+17.8%) |
| Dec 2016 | $1.06 M(+10.8%) | $1.06 M(+601.6%) |
| Sept 2016 | - | $150.50 K(-78.7%) |
| June 2016 | - | $705.30 K(+412.6%) |
| Mar 2016 | - | $137.60 K(-85.6%) |
| Dec 2015 | $953.20 K(+297.5%) | $953.20 K(+184.9%) |
| Sept 2015 | - | $334.60 K(-72.1%) |
| June 2015 | - | $1.20 M(-41.9%) |
| Mar 2015 | - | $2.06 M(+758.8%) |
| Dec 2014 | $239.80 K(-20.6%) | $239.80 K(-10.8%) |
| Sept 2014 | - | $268.90 K(+537.2%) |
| June 2014 | - | $42.20 K(-86.0%) |
| Dec 2013 | $302.20 K | $302.20 K |
FAQ
- What is BioSig Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioSig Technologies?
- What is BioSig Technologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioSig Technologies?
- What is BioSig Technologies quarterly cash and cash equivalents year-on-year change?
What is BioSig Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of BSGM is $190.00 K
What is the all time high annual cash & cash equivalents for BioSig Technologies?
BioSig Technologies all-time high annual cash & cash equivalents is $28.27 M
What is BioSig Technologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BSGM is $615.00 K
What is the all time high quarterly cash and cash equivalents for BioSig Technologies?
BioSig Technologies all-time high quarterly cash and cash equivalents is $36.93 M
What is BioSig Technologies quarterly cash and cash equivalents year-on-year change?
Over the past year, BSGM quarterly cash and cash equivalents has changed by +$425.00 K (+223.68%)